|
|
Diabetic Macular Edema: Employing Inflammatory Markers to Predict Improved Visual Outcomes
Real-world outcomes with intravitreal anti-vascular endothelial growth factor (VEGF) therapy in the treatment of patients with diabetic macular edema (DME) do not always replicate those seen in clinical studies. In part, these discrepancies are due to treatment burden, lack of adherence, undertreatment, and incomplete response to anti-VEGF therapies. The identification of several inflammatory cytokines in the aqueous and vitreous humor whose concentrations correlate closely with the severity o... |
|
|
Diabetic Macular Edema: Employing Inflammatory Markers to Predict Improved Visual Outcomes
Real-world outcomes with intravitreal anti-vascular endothelial growth factor (VEGF) therapy in the treatment of patients with diabetic macular edema (DME) do not always replicate those seen in clinical studies. In part, these discrepancies are due to treatment burden, lack of adherence, undertreatment, and incomplete response to anti-VEGF therapies. The identification of several inflammatory cytokines in the aqueous and vitreous humor whose concentrations correlate closely with the severity o... |
|
|
Ulcerative Colitis and the Role of S1P Receptor Modulators and JAK Inhibitors " A Wheel of Knowledge Challenge!
Ulcerative colitis (UC), a type of inflammatory bowel disease, is a chronic relapsing condition characterized by an overly active immune response in the large intestine, resulting in inflammation and ulceration. Given the increasing prevalence of disease and rapid influx of available biologics and small molecule therapies, there is great need for ongoing education regarding new and emerging treatment approaches for the management of UC. In this continuing education program, expert clinicians w... |
|
|
Cases in Practice: Applying Proposed Care Pathways for Interdisciplinary Collaboration to the Management of Nasal Polyps
Target Audience
The intended audience for this program is ENTs, allergists, immunologists, specialty nurse practitioners and physician assistants, and other clinicians involved in the management of patients with nasal polyps (NPs).
Program Overview
Clinicians on the frontlines of care for chronic rhinosinusitis with nasal polyps " including ear, nose, and throat specialists (ENTs) and allergists-- are largely unaware of the underlying pathophysiology driven by type 2 (T2) inflammatio... |
|
|
Seeking Control for Moderate-to-Severe Asthma: The Underestimated Impact of Comorbidities Along the Lifespan
Target Audience
The primary target audience for this activity are pulmonologists, allergists/immunologists, and specialty advanced practice providers (NPs and PAs). The secondary audience for this activity are primary care physicians, and general practice NPs and PAs.
Program Overview
Severe uncontrolled asthma leads to multiple negative health and socioeconomic effects. Asthma is also associated with comorbid conditions, some driven by shared type 2 inflammatory pathophysiology, includin... |
|